Sinining, Zandrie O.
HRN: 25-38-58 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2025
CEFUROXIME 750MG (VIAL)
12/16/2025
12/22/2025
IVT
180mg
Q8
Pneumonia; UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes